InvestorsHub Logo
Followers 2
Posts 29
Boards Moderated 0
Alias Born 07/05/2012

Re: ORCA post# 9066

Sunday, 04/19/2015 2:09:39 PM

Sunday, April 19, 2015 2:09:39 PM

Post# of 24874
ORCA,

Consider this:

Within the next 18-24 months, Erwin could push the company's annual revenues upwards of $40 million with roughly $5 million+ in cash flow. Let's say hypothetically we're at 500 million shares 24 months from now. Even if that's the case, with revenues at $35-40 million annually and cash flow at or around $5 million a year, plus an FDA approved product which unto itself will be a greater income-producing asset for the company in the months to come, the fundamentals of this company will have improved exponentially.

I also believe if this scenario were to play out, Erwin and Kramarz would possibly go forward with a 5-for-1 reverse split. It's obviously a lot easier to move the needle (stock price) with 100 million shares outstanding versus 500 million shares outstanding.

No one here wants dilution. I certainly don't. But we've got some housekeeping items to deal with, as you know, and in order to get to where we need to be, we're going to have to bite the bullet at times, whether it be dealing with the former CEO or one of the acquisitions and the associated debt and overhead with them. At this point I like what management has done with the acquisitions, because each of the companies we have acquired are running far more efficiently now than the day we bought them out.

Me personally, I see us getting the acquisition done at some point later this spring. My hope is that once this is done, management will take some additional time to focus on an uplisting to OTC-BB, given that we are indeed a fully reporting company. I know it is a priority.

In two years if we have the revenue and cash flow I mentioned above, then facilitate a reverse stock split, i see no reason why we couldn't be a $15 million dollar market cap company. At that point in time I think it would be well within reason to see us be considered for a spot on the AMEX. There are already numerous companies on the AMEX with a $20-25 million market cap with less than $10 million in annual revenues and less than $1 million cash flow.

We've got some more bumps to encounter this spring and into the summer IMO. But we're getting there.

Best to you sir.